Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review
- PMID: 397957
Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review
Abstract
Exposure of mammals to hormones and drugs during pregnancy sometimes results in profound consequences in the offspring. In this review, the long-term effects of perinatal exposure to hormones on the mammary gland in female rodents at advanced ages are discussed as a model for possible human consequences of antenatal exposure to sex hormones. In general, antenatal hormone treatments may influence the development and growth of the mammary gland. Perinatal treatment with estrogen, androgen, progesterone, or even prolactin in some cases induces not only irreversible abnormality of mammary growth but also influences spontaneous and carcinogen-induced mammary tumorigenesis. Effects of neonatal hormone treatment on mammary tumorigenesis, which appear to be mainly due to the endogenous hormone imbalance produced, vary according to the time and period of the treatment and to the species and/or strain employed.
Similar articles
-
Long-term effects of neonatal hormonal treatments on plasma prolactin levels in female BALB/cfC3H and BALB/c mice.Cancer Res. 1978 Apr;38(4):942-5. Cancer Res. 1978. PMID: 639048 No abstract available.
-
Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice.Cancer Res. 1977 Jan;37(1):67-75. Cancer Res. 1977. PMID: 830422
-
Growth of mouse mammary glands after neonatal sex hormone treatment.J Natl Cancer Inst. 1982 Dec;69(6):1347-52. J Natl Cancer Inst. 1982. PMID: 6958910
-
Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.In Vivo. 2008 Mar-Apr;22(2):191-201. In Vivo. 2008. PMID: 18468403 Review.
-
Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).Anticancer Res. 1983 Jul-Aug;3(4):273-81. Anticancer Res. 1983. PMID: 6309070 Review.
Cited by
-
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.Fertil Steril. 2008 Oct;90(4):911-40. doi: 10.1016/j.fertnstert.2008.08.067. Fertil Steril. 2008. PMID: 18929049 Free PMC article. Review.
-
Effects of sex hormones on oncogene expression in the vagina and on development of sexual dimorphism of the pelvis and anococcygeus muscle in the mouse.Environ Health Perspect. 1995 Oct;103 Suppl 7(Suppl 7):79-82. doi: 10.1289/ehp.95103s779. Environ Health Perspect. 1995. PMID: 8593880 Free PMC article. Review.
-
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.Rev Endocr Metab Disord. 2015 Dec;16(4):359-64. doi: 10.1007/s11154-016-9332-9. Rev Endocr Metab Disord. 2015. PMID: 26831296 Free PMC article. Review.
-
Establishing a framework for the functional mammary gland: from endocrinology to morphology.J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):17-38. doi: 10.1023/a:1015766322258. J Mammary Gland Biol Neoplasia. 2002. PMID: 12160083 Review.
-
Comparative effects of neonatal diethylstilbestrol on external genitalia development in adult males of two mouse strains with differential estrogen sensitivity.Differentiation. 2014 Sep-Oct;88(2-3):70-83. doi: 10.1016/j.diff.2014.09.004. Epub 2014 Oct 16. Differentiation. 2014. PMID: 25449353 Free PMC article.